<DOC>
	<DOCNO>NCT01349829</DOCNO>
	<brief_summary>This study test whether vaccination HAVpur Junior hepatitis A provide protection non-inferior protection afford vaccination Havrix 720 Junior .</brief_summary>
	<brief_title>A Study Evaluate Safety Immunogenicity Hepatitis A Virus Vaccine HAVpur Healthy Young Children</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female ( include ) 18 month 47 month age . Written inform consent obtain parent/legal guardian subject . Free obvious health problem establish medical history and/or clinical examination enter study Seropositive antiHAV antibody ( &gt; =10 mIU/ml ) . Use investigational nonregistered drug vaccine within 30 day precede first dose study vaccine , plan use study period safety followup . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within six month prior first vaccine dose ( corticosteroid , prednisone , equivalent , &gt; =0.5 mg/kg/day . Inhaled local steroid allow . ) Planned administration/ administration measles contain vaccine within 4 week prior first booster dose study vaccine . Previous vaccination hepatitis A . Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection . History allergic disease reaction likely exacerbate component vaccine . Major congenital defect serious chronic illness . Acute disease time enrolment</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>47 Months</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Hepatitis A</keyword>
	<keyword>Vaccination</keyword>
	<keyword>Immunity</keyword>
</DOC>